Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Aug;20(8):1961-1962.
doi: 10.1111/ajt.15875. Epub 2020 Apr 15.

CMV immune monitoring-Where do we go from here?

Deepali Kumar  1 , Atul Humar  1
Affiliations
Free article
Editorial

CMV immune monitoring-Where do we go from here?

Deepali Kumar et al. Am J Transplant. 2020 Aug.
Free article
No abstract available

Keywords: antibiotic: antiviral; antibiotic: antiviral-ganciclovir/valganciclovir; editorial/personal viewpoint; infectious disease; kidney transplantation/nephrology.

PubMed Disclaimer

Comment on

References

REFERENCES

    1. Kumar D, Chernenko S, Moussa G, et al. Cell-mediated immunity to predict cytomegalovirus disease in high-risk solid organ transplant recipients. Am J Transplant. 2009;9(5):1214-1222.
    1. Kotton CN, Kumar D, Caliendo AM, et al. The Third International Consensus Guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation. 2018;102(6):900-931.
    1. Fernandez-Ruiz M, Rodriguez-Goncer I, Parra P, et al. Monitoring of CMV-specific cell-mediated immunity with a commercial ELISA-based interferon-γ release assay in kidney transplant recipients treated with antithymocyte globulin. [published online ahead of print 2020]. Am J Transplant. https://doi.org/10.1111/ajt.15793
    1. Manuel O, Husain S, Kumar D, et al. Assessment of cytomegalovirus-specific cell-mediated immunity for the prediction of cytomegalovirus disease in high-risk solid-organ transplant recipients: a multicenter cohort study. Clin Infect Dis. 2013;56(6):817-824.
    1. Kumar D, Mian M, Singer L, Humar A. An Interventional Study using cell-mediated immunity to personalize therapy for cytomegalovirus infection after transplantation. Am J Transplant. 2017;17(9):2468-2473.